Regulation of TDP-43 aggregation by phosphorylation andp62/SQSTM1

Journal of Neurochemistry

Volumn 116, Issue 2, 2011, Pages 248-259

  Brady, Owen A ^a   Meng, Peter ^a   Zheng, Yanqiu ^a   Mao, Yuxin ^a   Hu, Fenghua ^a  

^a School of Integrative Plant Sciences   (United States)

Author keywords

aggregation; autophagy; p62 SQSTM1; phosphorylation; proteasome; TDP 43

Indexed keywords

ASPARTIC ACID; PROTEASOME; PROTEIN P62; SERINE; TAR DNA BINDING PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; AUTOPHAGY; CARBOXY TERMINAL SEQUENCE; EMBRYO; ENZYME INHIBITION; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEFECT; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; AUTOPHAGY; CERCOPITHECUS AETHIOPS; COS CELLS; DNA-BINDING PROTEINS; HEK293 CELLS; HUMANS; MICE; NIH 3T3 CELLS; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; RNA-BINDING PROTEINS;

EID: 78650680776     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.07098.x     Document Type: Article

References (57)

1. Amador-Ortiz C., Lin W. L., Ahmed Z., Personett D., Davies P., Duara R., Graff-Radford N. R., Hutton M. L., and, Dickson D. W., (2007) TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann. Neurol. 61, 435-445.
2. Amaravadi R. K., Yu D., Lum J. J., Bui T., Christophorou M. A., Evan G. I., Thomas-Tikhonenko A., and, Thompson C. B., (2007) Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J. Clin. Invest. 117, 326-336.
3. Arai T., Hasegawa M., Akiyama H., et al. (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 351, 602-611.
4. Babu J. R., Geetha T., and, Wooten M. W., (2005) Sequestosome 1/p62 shuttles polyubiquitinated tau for proteasomal degradation. J. Neurochem. 94, 192-203.
5. Barth S., Glick D., and, Macleod K. F., (2010) Autophagy: assays and artifacts. J. Pathol. 221, 117-124.
6. Baumer D., Hilton D., Paine S. M., Turner M. R., Lowe J., Talbot K., and, Ansorge O., (2010) Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations. Neurology 75, 611-618.
7. Buratti E., and, Baralle F. E., (2008) Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease. Front Biosci. 13, 867-878.
8. Buratti E., Brindisi A., Giombi M., Tisminetzky S., Ayala Y. M., and, Baralle F. E., (2005) TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail: an important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing. J. Biol. Chem. 280, 37572-37584.
9. Cohen N. R., Hammans S. R., Macpherson J., and, Nicoll J. A., (2010) New neuropathological findings in Unverricht-Lundborg disease: neuronal intranuclear and cytoplasmic inclusions. Acta Neuropathol. in press.
10. Deng H. X., Zhai H., Bigio E. H., et al. (2010) FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis. Ann. Neurol. 67, 739-748.
11. Dormann D., Capell A., Carlson A. M., et al. (2009) Proteolytic processing of TAR DNA binding protein-43 by caspases produces C-terminal fragments with disease defining properties independent of progranulin. J. Neurochem. 110, 1082-1094.
12. Dosztanyi Z., Csizmok V., Tompa P., and, Simon I., (2005) The pairwise energy content estimated from amino acid composition discriminates between folded and intrinsically unstructured proteins. J. Mol. Biol. 347, 827-839.
13. Filimonenko M., Stuffers S., Raiborg C., Yamamoto A., Malerod L., Fisher E. M., Isaacs A., Brech A., Stenmark H., and, Simonsen A., (2007) Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease. J. Cell Biol. 179, 485-500.
14. Foulds P., McAuley E., Gibbons L., Davidson Y., Pickering-Brown S. M., Neary D., Snowden J. S., Allsop D., and, Mann D. M., (2008) TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer's disease and frontotemporal lobar degeneration. Acta Neuropathol. 116, 141-146.
15. Fujita Y., Fujita S., Takatama M., Ikeda M., and, Okamoto K., (2010) Numerous FUS-positive inclusions in an elderly woman with motor neuron disease. Neuropathology [Epub ahead of print].
16. Gal J., Strom A. L., Kwinter D. M., Kilty R., Zhang J., Shi P., Fu W., Wooten M. W., and, Zhu H., (2009) Sequestosome 1/p62 links familial ALS mutant SOD1 to LC3 via an ubiquitin-independent mechanism. J. Neurochem. 111, 1062-1073.
17. Garcia-Arencibia M., Hochfeld W. E., Toh P. P., and, Rubinsztein D. C., (2010) Autophagy, a guardian against neurodegeneration. Semin. Cell Dev. Biol. 21, 691-698.
18. Geng J., and, Klionsky D. J., (2008) The Atg8 and Atg12 ubiquitin-like conjugation systems in macroautophagy. 'Protein modifications: beyond the usual suspects' review series. EMBO Rep. 9, 859-864.
19. Hara T., Nakamura K., Matsui M., et al. (2006) Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441, 885-889.
20. Hasegawa M., Arai T., Nonaka T., et al. (2008) Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann. Neurol. 64, 60-70.
21. Higashi S., Iseki E., Yamamoto R., et al. (2007) Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies. Brain Res. 1184, 284-294.
22. Igaz L. M., Kwong L. K., Chen-Plotkin A., Winton M. J., Unger T. L., Xu Y., Neumann M., Trojanowski J. Q., and, Lee V. M., (2009) Expression of TDP-43 C-terminal fragments in vitro recapitulates pathological features of TDP-43 proteinopathies. J. Biol. Chem. 284, 8516-8524.
23. Inukai Y., Nonaka T., Arai T., et al. (2008) Abnormal phosphorylation of Ser409/410 of TDP-43 in FTLD-U and ALS. FEBS Lett. 582, 2899-2904.
24. Jellinger K. A., (2008) Neuropathological aspects of Alzheimer disease, Parkinson disease and frontotemporal dementia. Neurodegener. Dis. 5, 118-121.
25. Ju J. S., Fuentealba R. A., Miller S. E., Jackson E., Piwnica-Worms D., Baloh R. H., and, Weihl C. C., (2009) Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease. J. Cell Biol. 187, 875-888.
26. Kabashi E., Valdmanis P. N., Dion P., et al. (2008) TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 40, 572-574.
27. Kadokura A., Yamazaki T., Kakuda S., Makioka K., Lemere C. A., Fujita Y., Takatama M., and, Okamoto K., (2009) Phosphorylation-dependent TDP-43 antibody detects intraneuronal dot-like structures showing morphological characters of granulovacuolar degeneration. Neurosci. Lett. 463, 87-92.
28. Kametani F., Nonaka T., Suzuki T., Arai T., Dohmae N., Akiyama H., and, Hasegawa M., (2009) Identification of casein kinase-1 phosphorylation sites on TDP-43. Biochem. Biophys. Res. Commun. 382, 405-409.
29. Kim S. H., Shanware N., Bowler M. J., and, Tibbetts R. S., (2010) ALS-associated proteins TDP-43 and FUS/TLS function in a common biochemical complex to coregulate HDAC6 mRNA. J. Biol. Chem. 285, 34097-34105.
30. Kwiatkowski T. J., Jr, Bosco D. A., Leclerc A. L., et al. (2009) Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323, 1205-1208.
31. Ling S. C., Albuquerque C. P., Han J. S., Lagier-Tourenne C., Tokunaga S., Zhou H., and, Cleveland D. W., (2010) ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS. Proc. Natl Acad. Sci. USA 107, 13318-13323.
32. Nakashima-Yasuda H., Uryu K., Robinson J., et al. (2007) Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol. 114, 221-229.
33. Neumann M., Sampathu D. M., Kwong L. K., et al. (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130-133.
34. Neumann M., Kwong L. K., Lee E. B., et al. (2009) Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol. 117, 137-149.
35. Nonaka T., Kametani F., Arai T., Akiyama H., and, Hasegawa M., (2009) Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43. Hum. Mol. Genet. 18, 3353-3364.
36. Pankiv S., Clausen T. H., Lamark T., Brech A., Bruun J. A., Outzen H., Overvatn A., Bjorkoy G., and, Johansen T., (2007) p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J. Biol. Chem. 282, 24131-24145.
37. Ross C. A., and, Poirier M. A., (2004) Protein aggregation and neurodegenerative disease. Nat. Med. 10 (Suppl.), S10-S17.
38. Rutherford N. J., Zhang Y. J., Baker M., et al. (2008) Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. PLoS Genet. 4, e1000193.
39. Schwab C., Arai T., Hasegawa M., Yu S., and, McGeer P. L., (2008) Colocalization of transactivation-responsive DNA-binding protein 43 and huntingtin in inclusions of huntington disease. J. Neuropathol. Exp. Neurol. 67, 1159-1165.
40. Seibenhener M. L., Babu J. R., Geetha T., Wong H. C., Krishna N. R., and, Wooten M. W., (2004) Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation. Mol. Cell. Biol. 24, 8055-8068.
41. Seibenhener M. L., Geetha T., and, Wooten M. W., (2007) Sequestosome 1/p62-more than just a scaffold. FEBS Lett. 581, 175-179.
42. Shan X., Chiang P. M., Price D. L., and, Wong P. C., (2010) Altered distributions of Gemini of coiled bodies and mitochondria in motor neurons of TDP-43 transgenic mice. Proc. Natl Acad. Sci. USA 107, 16325-16330.
43. Sreedharan J., Blair I. P., Tripathi V. B., et al. (2008) TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319, 1668-1672.
44. Su V., and, Lau A. F., (2009) Ubiquitin-like and ubiquitin-associated domain proteins: significance in proteasomal degradation. Cell. Mol. Life Sci. 66, 2819-2833.
45. Uryu K., Nakashima-Yasuda H., Forman M. S., et al. (2008) Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. J. Neuropathol. Exp. Neurol. 67, 555-564.
46. Vance C., Rogelj B., Hortobagyi T., et al. (2009) Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323, 1208-1211.
47. Vancha A. R., Govindaraju S., Parsa K. V., Jasti M., Gonzalez-Garcia M., and, Ballestero R. P., (2004) Use of polyethyleneimine polymer in cell culture as attachment factor and lipofection enhancer. BMC Biotechnol. 4, 23.
48. Wang I. F., Wu L. S., and, Shen C. K., (2008) TDP-43: an emerging new player in neurodegenerative diseases. Trends Mol. Med. 14, 479-485.
49. Wegorzewska I., Bell S., Cairns N. J., Miller T. M., and, Baloh R. H., (2009) TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc. Natl Acad. Sci. USA 106, 18809-18814.
50. Wils H., Kleinberger G., Janssens J., Pereson S., Joris G., Cuijt I., Smits V., Ceuterick-de Groote C., Van Broeckhoven C., and, Kumar-Singh S., (2010) TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Proc. Natl Acad. Sci. USA 107, 3858-3863.
51. Winton M. J., Igaz L. M., Wong M. M., Kwong L. K., Trojanowski J. Q., and, Lee V. M., (2008) Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation. J. Biol. Chem. 283, 13302-13309.
52. Yang Z., and, Klionsky D. J., (2009) Mammalian autophagy: core molecular machinery and signaling regulation. Curr. Opin. Cell Biol. 22, 124-131.
53. Yen H. C., and, Elledge S. J., (2008) Identification of SCF ubiquitin ligase substrates by global protein stability profiling. Science 322, 923-929.
54. Yokoseki A., Shiga A., Tan C. F., et al. (2008) TDP-43 mutation in familial amyotrophic lateral sclerosis. Ann. Neurol. 63, 538-542.
55. Zhang Y. J., Xu Y. F., Dickey C. A., Buratti E., Baralle F., Bailey R., Pickering-Brown S., Dickson D., and, Petrucelli L., (2007) Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43. J. Neurosci. 27, 10530-10534.
56. Zhang Y. J., Xu Y. F., Cook C., et al. (2009) Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc. Natl Acad. Sci. USA 106, 7607-7612.
57. Zhang Y. J., Gendron T. F., Xu Y. F., Ko L. W., Yen S. H., and, Petrucelli L., (2010) Phosphorylation regulates proteasomal-mediated degradation and solubility of TAR DNA binding protein-43 C-terminal fragments. Mol. Neurodegener. 5, 33.